Manufacturer discounts on the price of branded drugs provided to Medicare Part D beneficiaries in the coverage gap will increase from 50% to 70% beginning in 2019 under federal budget legislation under consideration in the Senate.
Development of a Senate plan that would extend the budget at least through mid-March 2019. Once the Senate has passed...






